Symptom-centric view

Multiple sclerosis

Substances reporting Multiple sclerosis disproportionately — ranked by ROR.

showing 27 of 27

Substance ↓	ROR [95% CI]	Reports	Category	Label
ublituximab —	8.6 [6.8–10.9]	71	algemeen	new
teriflunomide —	23.5 [22.5–24.6]	2,217	algemeen	new
siponimod —	25.4 [23.1–27.8]	484	algemeen	new
peginterferon beta-1a —	19.6 [18.0–21.4]	558	algemeen	new
ozanimod hydrochloride —	9.6 [8.2–11.1]	174	algemeen	new
oxybutynin chloride —	7.5 [6.4–8.9]	146	algemeen	new
ofatumumab —	20.6 [19.5–21.8]	1,439	algemeen	new
ocrelizumab —	23.5 [22.6–24.4]	2,964	algemeen	new
natalizumab —	30.8 [30.1–31.5]	9,735	algemeen	new
modafinil —	9.6 [8.9–10.3]	684	algemeen	new
interferon beta-1b —	28.8 [27.2–30.6]	1,166	algemeen	new
interferon beta-1a —	27.3 [26.6–27.9]	9,327	algemeen	new
glatiramer acetate injection —	63.6 [58.3–69.5]	582	algemeen	new
glatiramer acetate —	25.8 [24.9–26.8]	3,206	algemeen	new
glatiramer —	25.6 [24.7–26.6]	3,253	algemeen	new
fingolimod hydrochloride —	30.5 [27.2–34.2]	314	algemeen	new
fingolimod hcl —	13.1 [12.5–13.6]	2,409	algemeen	new
fingolimod —	13.2 [12.7–13.8]	2,454	algemeen	new
diroximel fumarate —	44.8 [42.0–47.8]	1,063	algemeen	new
dimethyl fumarate kit —	20.5 [17.3–24.2]	144	algemeen	new
dimethyl fumarate —	24.0 [23.4–24.7]	5,723	algemeen	new
dextromethorphan hydrobromide and quinidine sulfate —	6.8 [5.2–8.9]	56	algemeen	new
dalfampridine —	21.1 [20.3–21.9]	3,117	algemeen	new
cladribine —	12.0 [10.6–13.6]	249	algemeen	new
baclofen —	12.4 [11.9–12.9]	2,324	algemeen	new
amantadine hydrochloride —	12.2 [10.3–14.5]	132	algemeen	new
amantadine —	7.8 [7.0–8.7]	350	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).